[{"address1": "Philip Heymans Alle 3", "city": "Hellerup", "zip": "2900", "country": "Denmark", "phone": "45 33 26 83 83", "website": "https://www.bavarian-nordic.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for immunization against typhoid fever. It is also developing MVA-BN WEV for the treatment of encephalitis viruses. It operates in the United States, Denmark, Canada, France, Germany, Singapore, Finland, Netherlands, Switzerland, Sweden, Taiwan, Saudi Arabia, Belgium, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.", "fullTimeEmployees": 1667, "companyOfficers": [{"maxAge": 1, "name": "Dr. Paul John Chaplin MSc, Ph.D.", "age": 57, "title": "CEO & President", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 3663529, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Henrik  Juuel M.Sc.", "age": 59, "title": "CFO & Executive VP", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 1684936, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Russell  Thirsk M.Sc.", "age": 56, "title": "Executive VP & COO", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rolf Sass Sorensen", "title": "Vice President of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Nicole  Seroff", "title": "Vice President Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jean-Christophe  May M.B.A., Pharm.D.", "age": 57, "title": "Executive VP & Chief Commercial Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.bavarian-nordic.com/investor.aspx", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.55, "open": 9.75, "dayLow": 9.71, "dayHigh": 9.77, "regularMarketPreviousClose": 9.55, "regularMarketOpen": 9.75, "regularMarketDayLow": 9.71, "regularMarketDayHigh": 9.77, "exDividendDate": 1585267200, "payoutRatio": 0.0, "beta": 1.096, "trailingPE": 10.554348, "volume": 1376, "regularMarketVolume": 1376, "averageVolume": 4161, "averageVolume10days": 5900, "averageDailyVolume10Day": 5900, "bid": 9.68, "ask": 9.8, "bidSize": 2500, "askSize": 700, "marketCap": 2279127808, "fiftyTwoWeekLow": 6.595, "fiftyTwoWeekHigh": 13.0, "allTimeHigh": 14.6, "allTimeLow": 6.595, "priceToSalesTrailing12Months": 0.3530614, "fiftyDayAverage": 12.11044, "twoHundredDayAverage": 9.762605, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -771039680, "profitMargins": 0.22038001, "floatShares": 77680496, "sharesOutstanding": 234719649, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.00021, "impliedSharesOutstanding": 297419440, "bookValue": 154.761, "priceToBook": 0.062741905, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "earningsQuarterlyGrowth": 0.388, "netIncomeToCommon": 1422627968, "trailingEps": 0.92, "enterpriseToRevenue": -0.119, "enterpriseToEbitda": -0.359, "52WeekChange": -0.025510192, "SandP52WeekChange": 0.1198014, "quoteType": "EQUITY", "currentPrice": 9.71, "recommendationKey": "none", "totalCash": 1663092992, "totalCashPerShare": 21.361, "ebitda": 2148345088, "totalDebt": 136052000, "quickRatio": 1.584, "currentRatio": 3.345, "totalRevenue": 6455329792, "debtToEquity": 1.129, "revenuePerShare": 27.258047, "returnOnAssets": 0.0688, "returnOnEquity": 0.12652999, "grossProfits": 3427838976, "freeCashflow": -3204626432, "operatingCashflow": 1766713984, "earningsGrowth": 0.364, "revenueGrowth": 0.157, "grossMargins": 0.53101003, "ebitdaMargins": 0.3328, "operatingMargins": 0.22462, "financialCurrency": "DKK", "symbol": "BVNRY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "corporateActions": [], "regularMarketTime": 1762549200, "exchange": "PNK", "messageBoardId": "finmb_7687618", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Bavarian Nordic A/S", "longName": "Bavarian Nordic A/S", "fiftyTwoWeekLowChange": 3.1150002, "fiftyTwoWeekLowChangePercent": 0.47232756, "fiftyTwoWeekRange": "6.595 - 13.0", "fiftyTwoWeekHighChange": -3.29, "fiftyTwoWeekHighChangePercent": -0.2530769, "fiftyTwoWeekChangePercent": -2.5510192, "dividendDate": 1586131200, "earningsTimestamp": 1755860340, "earningsTimestampStart": 1755860340, "earningsTimestampEnd": 1755860340, "earningsCallTimestampStart": 1746792000, "earningsCallTimestampEnd": 1746792000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 0.92, "fiftyDayAverageChange": -2.4004402, "fiftyDayAverageChangePercent": -0.19821246, "twoHundredDayAverageChange": -0.052604675, "twoHundredDayAverageChangePercent": -0.005388385, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1723728600000, "regularMarketChange": 0.15999985, "regularMarketDayRange": "9.71 - 9.77", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 4161, "regularMarketChangePercent": 1.6753911, "regularMarketPrice": 9.71, "marketState": "CLOSED", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]